Speaker illustration

Doctor Matteo Pelliccia

S. Giovanni Evangelista Hospital, Tivoli (Italy)

Chronic kidney disease impact after mitraclip therapy: five-year outcomes from the GRASP registry

Event: Heart Failure 2021

Topic: Mitral Valve Intervention

Session: Valvular Heart Disease and Interventional Cardiology


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb